According to investment bank Morgan Stanley, Chewy is projected to hit EBITDA (earnings before interest, taxes, depreciation and amortization) of $750 million (€673.6M) to $800 million (€763.5M) in fiscal year (FY) 2025.
Their analysis anticipates a 6.1% earnings growth for FY2025, compared to 5.5% in FY2024.
This is supported by the company’s efforts to expand its growth through initiatives such as sponsored ads and automation upgrades in its distribution centers, which are running at 75% capacity.
Although revenue growth is expected to be modest at around 4.7% in FY2025, Morgan Stanley notes that Chewy is still seen as a leader in the US pet market.
The pet retailer’s income per active customer is also forecast to rise from $554 (€496.78) to $586.50 (€525.92), aided by the company’s expanding product offerings in areas like pharmacy, private label products and pet health services.
Stock price increase
With Chewy’s stock price sitting at $26 (€23.31) in September 2024, analysts have predicted this to rise to anywhere from $49 (€44) to $53 (€47.53) in 2025, projecting a maximum 102.6% increase. The company is also forecast to reach $1 billion (€898.2M) in EBITDA by FY2026.
Adjustments in selling, general and administrative expenses (SG&A), i.e., all non-production costs, are likely to contribute toward the FY2025 predictions.
Analysts also point to a projected -1% year-on-year (YoY) reduction in fulfillment costs per order (merchant fees and customer service).
According to Morgan Stanley, Chewy has consistently managed expenses effectively, even during inflationary periods such as 2020 and 2021.
Risks remain
Despite the optimistic outlook, several risks could impede Chewy’s margin expansion.
The main one is the broader pet market, which, if it weakens, could force Chewy to increase investment or lose efficiency.
Another risk is the company’s vet clinic expansion; analysts view this investment as modest, with only 8-10 openings in FY2024.
Increased promotions may push Chewy to spend more on acquiring customers through discounts and hurt profit margins.
It’s worth noting that Chewy’s most recent quarter was strong, with YoY sales in Q2 2024 increasing by 2.6% against last year.
The latest articles
These pet players are expanding their reach through retail partnerships
Pet brands are increasingly partnering with distribution companies to increase their product reach and tap into new markets.
Indian insect player secures permit to export to Europe
Arthro Biotech outlines ambitious plans to increase production to 100,000 tons annually by 2030.
AgroBiothers makes second acquisition in European pet care space
The addition of Denmark’s leading pet care business, KW, marks a strategic move to strengthen the French pet care company’s position in Northern Europe.
Weekly newsletter to stay up-to-date
Discover what’s happening in the pet industry. Get the must-read stories and insights in your inbox.